Literature DB >> 18286685

Diagnosis and management of relapsing pancreatitis associated with cystic neoplasms of the pancreas.

William-R Brugge1.   

Abstract

One of the most important causes of relapsing pancreatitis is a cystic neoplasm of the pancreas. These low grade malignancies may cause pancreatitis by obstructing or communicating with a pancreatic duct. Patients with relapsing pancreatitis and a focal fluid fluid collection should be investigated for the possibility of a mucinous cystic neoplasm. Cross sectional imaging can provide a diagnosis with the imaging findings of a low attenuation cystic lesion containing mural calcification (CT scanning) or a lobular T2 enhancing lesion (MRCP). Endoscopic ultrasound can provide more detailed imaging with the ability to guide fine needle aspiration of the cyst fluid. Cyst fluid analysis can provide a diagnosis of a mucinous cystic lesion with the combination of cytology (mucinous epithelium), elevated carcinoembryonic antigen (CEA), and the presence of DNA mutations. Management of these patients consists of surgical resection and monitoring in patients not able to withstand surgery.

Entities:  

Mesh:

Year:  2008        PMID: 18286685      PMCID: PMC2689406          DOI: 10.3748/wjg.14.1038

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  37 in total

1.  Allelic deletion and mutation of the von Hippel-Lindau (VHL) tumor suppressor gene in pancreatic microcystic adenomas.

Authors:  A O Vortmeyer; I A Lubensky; F Fogt; W M Linehan; U Khettry; Z Zhuang
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

Review 2.  Imaging diagnosis of cystic pancreatic lesions: pseudocyst versus nonpseudocyst.

Authors:  Young H Kim; Sanjay Saini; Dushant Sahani; Peter F Hahn; Peter R Mueller; Yong H Auh
Journal:  Radiographics       Date:  2005 May-Jun       Impact factor: 5.333

3.  Cystic neoplasms of the pancreas: evaluation with endoscopic retrograde pancreatography.

Authors:  G S Gazelle; P R Mueller; N Raafat; E F Halpern; G Cardenosa; A L Warshaw
Journal:  Radiology       Date:  1993-09       Impact factor: 11.105

4.  Intraductal papillary mucinous neoplasms of the pancreas: CT patterns of recurrence and multiobserver performance in detecting recurrent neoplasm after surgical resection.

Authors:  Jared A Christensen; J G Fletcher; Jeff L Fidler; Peter B Wold; Aaron J Binstock; Thomas Smyrk; Scott W Harmsen; Brian S Crownhart; Suresh Chari
Journal:  AJR Am J Roentgenol       Date:  2004-11       Impact factor: 3.959

5.  EUS findings in patients with autoimmune pancreatitis.

Authors:  James J Farrell; John Garber; Dushyant Sahani; William R Brugge
Journal:  Gastrointest Endosc       Date:  2004-12       Impact factor: 9.427

6.  A prospective comparison of the yield of EUS in primary vs. recurrent idiopathic acute pancreatitis.

Authors:  Ian F Yusoff; Ginette Raymond; Anand V Sahai
Journal:  Gastrointest Endosc       Date:  2004-11       Impact factor: 9.427

7.  The role of pancreatic cyst fluid molecular analysis in predicting cyst pathology.

Authors:  Asif Khalid; Kevin M McGrath; Maliha Zahid; Matt Wilson; Debra Brody; Patricia Swalsky; Arthur J Moser; Kenneth K Lee; Adam Slivka; David C Whitcomb; Sydney Finkelstein
Journal:  Clin Gastroenterol Hepatol       Date:  2005-10       Impact factor: 11.382

8.  Macrocystic pancreatic cystadenoma: The role of EUS and cyst fluid analysis in distinguishing mucinous and serous lesions.

Authors:  Dermot O'Toole; Laurent Palazzo; Pascal Hammel; Lamia Ben Yaghlene; Anne Couvelard; Michèle Felce-Dachez; Monique Fabre; Alain Dancour; Alain Aubert; Alain Sauvanet; Frédérique Maire; Philippe Lévy; Philippe Ruszniewski
Journal:  Gastrointest Endosc       Date:  2004-06       Impact factor: 9.427

9.  Signs and symptoms of pancreatic cancer: a population-based case-control study in the San Francisco Bay area.

Authors:  Elizabeth A Holly; Indranushi Chaliha; Paige M Bracci; Manjushree Gautam
Journal:  Clin Gastroenterol Hepatol       Date:  2004-06       Impact factor: 11.382

10.  Immunohistochemical analysis of molecular biological factors in intraductal papillary-mucinous tumors and mucinous cystic tumors of the pancreas.

Authors:  H Sawai; Y Okada; H Funahashi; Y Matsuo; M Tanaka; T Manabe
Journal:  Scand J Gastroenterol       Date:  2004-11       Impact factor: 2.423

View more
  4 in total

Review 1.  [Cystic tumors of the pancreas].

Authors:  R Grützmann; H-D Saeger
Journal:  Chirurg       Date:  2010-08       Impact factor: 0.955

Review 2.  Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer.

Authors:  Chitta Ranjan Patra; Resham Bhattacharya; Debabrata Mukhopadhyay; Priyabrata Mukherjee
Journal:  Adv Drug Deliv Rev       Date:  2009-11-13       Impact factor: 15.470

Review 3.  Elevating pancreatic cystic lesion stratification: Current and future pancreatic cancer biomarker(s).

Authors:  Joseph Carmicheal; Asish Patel; Vipin Dalal; Pranita Atri; Amaninder S Dhaliwal; Uwe A Wittel; Mokenge P Malafa; Geoffrey Talmon; Benjamin J Swanson; Shailender Singh; Maneesh Jain; Sukhwinder Kaur; Surinder K Batra
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-10-30       Impact factor: 10.680

4.  A pancreatic mucinous cystic neoplasm undergoing intriguing morphological changes over time and associated with recurrent pancreatitis: A case report.

Authors:  Erika Shioyama; Akira Mitoro; Hiroyuki Ogawa; Takuya Kubo; Takahiro Ozutsumi; Koh Kitagawa; Masaaki Yoshikawa; Shigehiko Ueda; Takahiro Akahori; Naga-Aki Marugami; Kinta Hatakeyama; Junichi Yamao; Masayuki Sho; Chiho Ohbayashi; Hitoshi Yoshiji
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.